Viatris Inc.
NASDAQ:VTRSDrug Manufacturers - Specialty & Generic
-$0.36 today
- Market cap
- $23.25B
- Beta
- 0.90
- P/E (TTM)
- -59.9
- EPS (TTM)
- -$0.26
- Dividend yield
- 3.12%
Volume 13.21M
Average 10.58M
VTRS Depreciation & Amortization
Non-cash expense that spreads the cost of physical and intangible assets over their useful lives.
Viatris Inc.NASDAQ: VTRS
Depreciation & Amortization · Q2 FY2026 · quarter ended Jun 2026
Depreciation & amortization dips below year-ago levels
Q2 FY2026 depreciation & amortization of $672.3M fell 0.9% year over year, behind the +1.6% change in trailing-twelve-month depreciation & amortization. Sequentially, it fell 0.6% from the prior quarter. Over 3 fiscal years it compounded at -2.6% a year.
Context
- Depreciation & amortization amounted to 19.6% of revenue in FY2025, up 1.2 pp from a year earlier.
- Depreciation & amortization increased in 1 of the last 3 fiscal years.
What to watch
Whether quarterly growth recovers from -0.9% toward the trailing-twelve-month pace of +1.6%.
Sources:Income StatementText generated from reported figures; not investment advice.
Depreciation & Amortization history
USD · from the income statement
- Latest · FY2025
- 2.8B USD
- Year-over-year change
- +3.3%
- 4-year CAGR
- -11.2%
| Period | Period end | Depreciation & Amortization | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 2.8B | +3.3% |
| FY2024 | 2024-12-31 | 2.71B | -1.2% |
| FY2023 | 2023-12-31 | 2.74B | -9.5% |
| FY2022 | 2022-12-31 | 3.03B | -32.8% |
| FY2021 | 2021-12-31 | 4.51B | — |
Depreciation & Amortization vs competitors
How VTRS compares with its peers on the latest reported figures
- Peers report in different currencies, so depreciation & amortization is compared through growth and share of revenue rather than absolute size.
- Its year-over-year change of +1.6% is the 5th highest of 9, against a peer median of +4.1%.
- Depreciation & amortization amounts to 19.0% of revenue for VTRS, versus a peer median of 6.2%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Sep 2026 | ₹21.51B INR | +12.7% | +19.7% | 6.5% | |
| LTM Jun 2026 | $2.8B USD | +1.6% | -2.6% | 19.0% | |
| LTM Jun 2026 | $1.17B USD | -5.6% | -4.7% | 10.8% | |
| LTM Jun 2026 | $989M USD | -3.3% | -8.5% | 5.7% | |
| LTM Jun 2025 | £379M GBP | — | +7.1% | 2.3% | |
| LTM Sep 2026 | $344M USD | +0.6% | +19.4% | 5.6% | |
| LTM Jun 2026 | $194.29M USD | -20.8% | -2.4% | 6.2% | |
| LTM Mar 2026 | $89.45M USD | +17.8% | +15.3% | 9.7% | |
| LTM Sep 2026 | $80.71M USD | +167.6% | -29.6% | 4.6% | |
| LTM Mar 2026 | $62.85M USD | +7.5% | +30.7% | 8.7% | |
| Peer median (excluding VTRS) | — | +4.1% | +7.1% | 6.2% | |
Competitors are the stored peer set for VTRS. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Income Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Revenue | 17.89B | 16.26B | 15.43B | 14.74B | 14.3B |
| Cost of Revenue | 12.31B | 9.77B | 8.99B | 9.12B | 9.29B |
| Gross Profit | 5.58B | 6.5B | 6.44B | 5.62B | 5.01B |
| Gross Margin | 31.2% | 40.0% | 41.7% | 38.2% | 35.1% |
| Research & Development | 681M | 662.2M | 805.2M | 808.7M | 965.9M |
| Selling, General & Admin | 4.53B | 4.18B | 4.65B | 4.43B | 3.79B |
| Operating Expenses | 5.61B | 4.88B | 5.67B | 5.61B | 7.68B |
| Depreciation & Amortization | 4.51B | 3.03B | 2.74B | 2.71B | 2.8B |
| EBITDA | 4.48B | 6.43B | 3.52B | 2.64B | (395.4M) |
| EBITDA Margin | 25.0% | 39.6% | 22.8% | 17.9% | -2.8% |
| Operating Income | (34M) | 1.61B | 766.2M | 10.1M | (2.66B) |
| Operating Margin | -0.2% | 9.9% | 5.0% | 0.1% | -18.6% |
| Interest Income | 0 | 0 | 0 | 0 | 0 |
| Interest Expense | 636.2M | 592.4M | 573.1M | 550M | 471.3M |
| Other Income / Expenses | (630.4M) | 1.2B | (563.3M) | (633.3M) | (1B) |
| Income Before Tax | (664.4M) | 2.81B | 202.9M | (623.2M) | (3.67B) |
| Pre-Tax Margin | -3.7% | 17.3% | 1.3% | -4.2% | -25.6% |
| Income Tax Expense | 604.7M | 734.6M | 148.2M | 11M | (150.1M) |
| Net Income | (1.27B) | 2.08B | 54.7M | (634.2M) | (3.51B) |
| Net Margin | -7.1% | 12.8% | 0.4% | -4.3% | -24.6% |
| EPS (Basic) | (1.05) | 1.71 | 0.05 | (0.53) | (3.00) |
| EPS (Diluted) | (1.05) | 1.71 | 0.05 | (0.53) | (3.00) |
| Weighted Avg Shares | 1.21B | 1.21B | 1.2B | 1.19B | 1.17B |
| Weighted Avg Shares (Diluted) | 1.21B | 1.22B | 1.21B | 1.19B | 1.17B |
Viatris Inc.
NASDAQ:VTRS
Intrinsic Alpha fair value
Locked
Current Price
$20.28
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.